GILD vs TBBK · P/E 18, rev $7.80B vs P/E 11, rev $261.8M
Gilead Sciences Inc (GILD) versus The Bancorp Inc (TBBK) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
The Bancorp Inc (TBBK) is a banks - regional company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported TBBK revenue for 2026-06-30 was $261.8M. Net income was $120.7M. TBBK currently screens at market cap $2.30B and trailing P/E 10.8.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. TBBK currently screens at market cap $2.30B and trailing P/E 10.8.
Not investment advice. Open the GILD and TBBK stock pages for the full models.
Not investment advice.